BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 9, 2016
View Archived Issues
Capella BioScience completes series A financing to progress antibody pipeline
Read More
Omeros initiates its phase III program for OMS-721
Read More
Sanofi Pasteur and Merck & Co. announce intent to end joint vaccines operations in Europe
Read More
XBiotech submits MAA for candidate colorectal cancer therapy
Read More
Jiangsu Hengrui Medicine discloses SLC34A2 inhibitors
Read More
Eisai patents FGFR-1 inhibitors
Read More
Teligene presents protein kinase inhibitors
Read More
GeoVax Labs reports findings on simian analogue of GOVX-B11 HIV vaccine
Read More
Stealth BioTherapeutics begins phase II trial of elamipretide in FCED
Read More
RedHill Biopharma reports final phase III results for RHB-105
Read More
Liver injury model reveals role of CD147 in inflammation in liver disease
Read More
Citius Pharmaceuticals signs letter of intent to acquire Leonard Meron Biosciences
Read More
EyeGate acquires Jade Therapeutics
Read More
Study shows p-Tau and Ki-67 as valid biomarkers in skin cancer
Read More
Affymetrix awarded grant to assess value of noninvasive genomic profiling of bladder cancer
Read More
Theranostics Health to join Amarantus Diagnostics and Avant Diagnostics business combination
Read More
HLA allele associated with hidradenitis suppurativa
Read More
Novel tumorigenic driver mutations identified in basal cell carcinoma of the skin
Read More
Helix announces amendments to phase I/II study of L-DOS-47 in Poland
Read More
Bio-Path enters sponsored pancreatic cancer research agreement with MD Anderson
Read More
Ipsen and PeptiMimesis establish research partnership for novel therapeutic peptides in oncology
Read More
Inhibitor of apoptosis protein BIRC3 affects response to glioblastoma therapy
Read More
CFDA approves Roche's CINtec PLUS Cytology test
Read More